Global Topical Drugs Market

Topical Drugs Market Size, Share, Growth Analysis, By Type(Semi-solid, Liquid), By Route of administration(Dermal, Ophthalmic), By End-user(Burn Centers, Hospitals & Clinics), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2309 | Region: Global | Published Date: February, 2024
Pages: 219 | Tables: 87 | Figures: 76

Topical Drugs Market Dynamics

Drivers

Aging Population and Skin Health Awareness

One predominant key driving force of the topical tablets marketplace is the getting older populace. As the worldwide population keeps aging, there's a growing demand for skin care and dermatological treatments to cope with age-associated skin issues. Additionally, expanded focus approximately on pores and skin health and the preference for youthful appearances are motivating purchasers to try to find topical answers, using market increase.

Restraints

Stringent Regulatory Requirements

The approval system for topical medications can be prolonged and highly-priced, requiring good sized clinical trials and safety tests. These rules can gradually down product development and market access, posing a undertaking for pharmaceutical groups aiming to bring new topical capsules to the marketplace.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Topical Drug Delivery Market size was valued at USD 204.6 billion in 2022 and is poised to grow from USD 222.2 billion in 2023 to USD 429.9 billion by 2031, growing at a CAGR of 8.6% in the forecast period (2024-2031).

The aggressive landscape in the international topical tablets marketplace is marked by means of a diverse array of pharmaceutical organizations and producers striving to fulfill the developing demand for skin care and dermatological answers. These enterprise players have interaction in widespread studies and development efforts to formulate progressive topical treatments. 'Bayer AG (Germany)', 'Cipla Inc. (India)', 'Galderma S.A. (Switzerland)', 'GSK Group of Companies (UK)', 'Johnson & Johnson Private Ltd. (US)', 'Novartis AG (Switzerland)', 'Amgen Inc. (US)', 'Bausch Health Companies Inc. (Canada)', 'Astellas Pharma Inc. (Japan)', 'Hisamitsu Pharmaceuticals Co. Inc. (Japan)', 'Merck & Co., Inc. (US)', 'LEO Pharma A/S (Denmark)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Glenmark Pharmaceuticals Ltd. (India)', 'Eli Lilly and Company (US)', 'MedPharm Ltd. (UK)', 'AbbVie Inc. (US)', 'Sun Pharmaceutical Industries Ltd. (India)', 'Pfizer Inc. (US)', 'Fresenius SE & Co. KGaA (Germany)'

Rise of Telemedicine and E-Pharmacies: Telemedicine platforms have been gaining traction all over the world owing to their convenience and effectiveness, especially in the field of dermatology. The growing need for contactless healthcare, improved access to healthcare, and rising preference for online purchase of medications are factors that are driving the demand for topical drugs through e-pharmacies and telemedicine platforms over the coming years.

North America presently dominates the global topical drugs marketplace. This dominance may be attributed to several elements, including a well-mounted healthcare infrastructure, high consumer awareness about skincare, and a strong pharmaceutical enterprise. Additionally, a sturdy emphasis on research and development, together with the presence of main pharmaceutical businesses inside the region, contributes to North America's management in this marketplace.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Topical Drugs Market

Report ID: SQMIG35I2309

$5,300
BUY NOW GET FREE SAMPLE